학술논문

A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
Document Type
Report
Author abstract
Source
Journal for ImmunoTherapy of Cancer. November 4, 2015, Vol. 3 Issue Suppl 2
Subject
Company growth
T cells -- Growth
Cellular therapy -- Innovations
Multiple myeloma -- Care and treatment
Cell receptors -- Properties -- Growth
Language
English
ISSN
2051-1426
Abstract
Author(s): Alden Ladd[sup.1] , Graham Lilley[sup.1] , Mingli Li[sup.1] , Dan Cossette[sup.1] , Gregory W Hopkins[sup.1] , Dawn Maier[sup.1] , Michael Paglia[sup.1] and Richard A Morgan[sup.1] Adoptive transfer of autologous [...]